In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that consumer prices can be lowered without sacrificing profit margin. Fortunately ...

Overall, average healthcare costs increased 46% over two years for patients trying GLP-1 drugs for obesity, from $12,695 to $18,507. The Congressional Budget Office states that there does not ...

They were on the hook for 5% of their drugs’ cost in the so-called catastrophic coverage phase, which, in 2023, began when they hit $7,400 in out-of-pocket spending. The federal government paid ...

The cost of Pristiq can vary based on several factors, including whether you have insurance coverage. Drug savings programs can also lower the price you’ll pay for Pristiq. The active ingredient ...

Neu­ro­science drug de­vel­op­er Neumo­ra Ther­a­peu­tics re­leased high­ly an­tic­i­pat­ed re­sults from the first of three Phase 3 tri­als for its ex­per­i­men­tal ma­jor … ...

It is playing catch-up with a rival Lp(a) targeting antisense drug from Novartis and development partner Akcea, called pelacarsen, which is already in a phase 3 trial called HORIZON with major ...

and that drug was tens of thousands of dollars, that could translate into potentially thousands of dollars of out-of-pocket costs,” said Matthew Fiedler, senior fellow at the Brookings Institution.

Your institution has access to JSTOR’s AI-powered research tool in beta. Log in or create a JSTOR personal account to get started.

Drug discovery and development together are the complete process of identifying a new drug and bringing it to market. Discovery may involve screening of chemical libraries, identification of the ...

The bill (S 3012) that popped out of months of private talks late Friday would also add scrutiny to pharmacy benefit managers, and eliminate or cap out-of-pocket costs for drugs that treat certain ...

They were on the hook for 5% of their drugs’ cost in the so-called catastrophic coverage phase, which, in 2023, began when they hit $7,400 in out-of-pocket spending. The federal government paid 80% of ...